{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:24:09Z","timestamp":1778538249899,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive fungal disease (IFD) early diagnosis improves hematological patient survival. Non-culture-based methods may reduce diagnostic time to identify IFD. As complex data on the value of 1,3-\u03b2-<jats:sc>d<\/jats:sc>-glucan (BDG) from bronchoalveolar lavage fluid (BALF) compared to serum for the most frequent invasive pulmonary aspergillosis (IPA) diagnosis are scarce, particularly including evaluation of potential factors adversely affecting BDG assay, we provided prospective single-center analysis evaluating 172 episodes of pulmonary infiltrates with BDG detection in BALF and serum samples collected in parallel among hematological patients from 2006 to 2015. Proven and probable IPA were documented in 13.4% of the episodes. Sensitivity (SEN), specificity (SPE), positive and negative predictive value (PPV; NPV), and diagnostic odds ratio (DOR) of the BDG assay using standard (80\u00a0pg\/ml) cut-off for BALF were: 56.5%; 83.2%; 34.2%; 92.5%, and 6.5, respectively, and for serum were: 56.5%; 82.6%; 33.3%; 92.5%, and 6.2, respectively. The same BDG assay parameters employing a calculated optimal cut-off for BALF (39\u00a0pg\/ml) were: 78.3%; 72.5%; 30.5%; 95.6%, and 9.5, respectively; and for serum (40\u00a0pg\/ml) were: 73.9%; 69.1%; 27.0%; 94.5%, and 6.3, respectively. While identifying acceptable SEN, SPE, and DOR, yet low PPV of both BALF and serum BDG assay for IPA diagnosis, neither the combination of both materials nor the new optimal BDG cut-off led to significant test quality improvement. Absolute neutrophil count and aspirated BALF volume with a significant trend affected BDG assay performance. The BDG test did not outperform galactomannan assay.<\/jats:p>","DOI":"10.1038\/s41598-020-75132-3","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:04:15Z","timestamp":1603274655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bronchoalveolar lavage fluid and serum 1,3-\u03b2-d-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance"],"prefix":"10.1038","volume":"10","author":[{"given":"Barbora","family":"Weinbergerova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Kabut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Kocmanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Lengerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Pospisil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Kral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"75132_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","volume":"1272","author":"R Herbrecht","year":"2012","unstructured":"Herbrecht, R., Bories, P., Moulin, J.-C., Ledoux, M.-P. & Letscher-Bru, V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann. N. Y. Acad. Sci. 1272, 23\u201330 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl 1","key":"75132_CR2","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jac\/dkq437","volume":"66","author":"L Pagano","year":"2011","unstructured":"Pagano, L. et al. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J. Antimicrob. Chemother. 66(Suppl 1), i5-14 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"75132_CR3","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.ijid.2012.09.004","volume":"17","author":"Z Racil","year":"2013","unstructured":"Racil, Z. et al. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: fungal infection database (FIND) analysis, 2005\u20132009. Int. J. Infect. Dis. 17, e101-109 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"75132_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw, B. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin. Infect. Dis. 46, 1813\u20131821 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","author":"JP Donnelly","year":"2019","unstructured":"Donnelly, J. P. et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciz1008 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos, D. et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48, 265\u2013273 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/cid\/ciq147","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld, A. G. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52, 427\u2013431 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ajcp\/aqy135","volume":"151","author":"SK White","year":"2019","unstructured":"White, S. K., Walker, B. S., Hanson, K. E. & Schmidt, R. L. Diagnostic accuracy of \u03b2-d-glucan (fungitell) testing among patients with hematologic malignancies or solid organ tumors: a systematic review and meta-analysis. Am. J. Clin. Pathol. 151, 275\u2013285 (2019).","journal-title":"Am. J. Clin. Pathol."},{"key":"75132_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson, T. F. et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 63, e1\u2013e60 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62, e1-50 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR11","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1128\/JCM.06423-11","volume":"50","author":"J D\u2019Haese","year":"2012","unstructured":"D\u2019Haese, J. et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J. Clin. Microbiol. 50, 1258\u20131263 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"75132_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007394.pub2","author":"MMG Leeflang","year":"2015","unstructured":"Leeflang, M. M. G. et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD007394.pub2 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"75132_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","volume":"4","author":"MASH Mennink-Kersten","year":"2004","unstructured":"Mennink-Kersten, M. A. S. H., Donnelly, J. P. & Verweij, P. E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4, 349\u2013357 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"75132_CR14","doi-asserted-by":"publisher","first-page":"e0131602","DOI":"10.1371\/journal.pone.0131602","volume":"10","author":"T-Y Hou","year":"2015","unstructured":"Hou, T.-Y. et al. The screening performance of serum 1,3-\u03b2-d-glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies. PLoS ONE 10, e0131602 (2015).","journal-title":"PLoS ONE"},{"key":"75132_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cid\/cir897","volume":"54","author":"F Lamoth","year":"2012","unstructured":"Lamoth, F. et al. \u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL-3). Clin. Infect. Dis. 54, 633\u2013643 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","volume":"48","author":"S He","year":"2015","unstructured":"He, S. et al. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-d-glucan for invasive fungal infection: focus on cutoff levels. J. Microbiol. Immunol. Infect. 48, 351\u2013361 (2015).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"75132_CR17","doi-asserted-by":"publisher","first-page":"21484","DOI":"10.18632\/oncotarget.7471","volume":"7","author":"E Azoulay","year":"2016","unstructured":"Azoulay, E. et al. (1, 3)-\u03b2-d-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget 7, 21484\u201321495 (2016).","journal-title":"Oncotarget"},{"key":"75132_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/ijms18040862","volume":"18","author":"E Levesque","year":"2017","unstructured":"Levesque, E. et al. Detection of (1,3)-\u03b2-d-glucan for the diagnosis of invasive fungal infection in liver transplant recipients. Int. J. Mol. Sci. 18, 862 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"75132_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","volume":"190","author":"J Prattes","year":"2014","unstructured":"Prattes, J. et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am. J. Respir. Crit. Care Med. 190, 922\u2013929 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"75132_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner, L. et al. Multicenter clinical evaluation of the (1 \u2192 3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41, 654\u2013659 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1469-0691.2010.03357.x","volume":"17","author":"J Acosta","year":"2011","unstructured":"Acosta, J. et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1 \u2192 3)-\u03b2-d-glucan chromogenic assay in serum samples. Clin. Microbiol. Infect. 17, 1053\u20131060 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"75132_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.rmed.2016.05.017","volume":"117","author":"X-Y Shi","year":"2016","unstructured":"Shi, X.-Y. et al. Diagnostic value of (1 \u2192 3)-\u03b2-d-glucan in bronchoalveolar lavage fluid for invasive fungal disease: a meta-analysis. Respir. Med. 117, 48\u201353 (2016).","journal-title":"Respir. Med."},{"key":"75132_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","volume":"69","author":"SR Rose","year":"2014","unstructured":"Rose, S. R. et al. The utility of bronchoalveolar lavage beta-d-glucan testing for the diagnosis of invasive fungal infections. J. Infect. 69, 278\u2013283 (2014).","journal-title":"J. Infect."},{"key":"75132_CR24","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1097\/TP.0000000000000635","volume":"99","author":"W Mutschlechner","year":"2015","unstructured":"Mutschlechner, W. et al. Bronchoalveolar lavage fluid (1,3)\u03b2-d-glucan for the diagnosis of invasive fungal infections in solid organ transplantation: a prospective multicenter study. Transplantation 99, e140-144 (2015).","journal-title":"Transplantation"},{"key":"75132_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11046-012-9579-y","volume":"175","author":"ES Theel","year":"2013","unstructured":"Theel, E. S. et al. Detection of (1, 3)-\u03b2-d-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia 175, 33\u201341 (2013).","journal-title":"Mycopathologia"},{"key":"75132_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","volume":"47","author":"T Boch","year":"2018","unstructured":"Boch, T. et al. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-d-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study. J. Crit. Care 47, 198\u2013203 (2018).","journal-title":"J. Crit. Care"},{"key":"75132_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-6515-1_11","volume":"1508","author":"B Weinbergerova","year":"2017","unstructured":"Weinbergerova, B., Kocmanova, I., Racil, Z. & Mayer, J. Serological approaches. Methods Mol. Biol. 1508, 209\u2013221 (2017).","journal-title":"Methods Mol. Biol."},{"key":"75132_CR28","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","volume":"43","author":"JW Pickering","year":"2005","unstructured":"Pickering, J. W., Sant, H. W., Bowles, C. A. P., Roberts, W. L. & Woods, G. L. Evaluation of a (1 \u2192 3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43, 5957\u20135962 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"75132_CR29","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1086\/588563","volume":"46","author":"MASH Mennink-Kersten","year":"2008","unstructured":"Mennink-Kersten, M. A. S. H., Ruegebrink, D. & Verweij, P. E. Pseudomonas aeruginosa as a cause of 1,3-beta-d-glucan assay reactivity. Clin. Infect. Dis. 46, 1930\u20131931 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"75132_CR30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10096-011-1244-8","volume":"30","author":"O Albert","year":"2011","unstructured":"Albert, O. et al. Reactivity of (1 \u2192 3)-\u03b2-d-glucan assay in bacterial bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1453\u20131460 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"75132_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1099\/jmm.0.47479-0","volume":"57","author":"M Ellis","year":"2008","unstructured":"Ellis, M. et al. Assessment of the clinical utility of serial beta-d-glucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol. 57, 287\u2013295 (2008).","journal-title":"J. Med. Microbiol."},{"key":"75132_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","volume":"59","author":"Z Racil","year":"2010","unstructured":"Racil, Z. et al. Difficulties in using 1,3-{beta}-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J. Med. Microbiol. 59, 1016\u20131022 (2010).","journal-title":"J. Med. Microbiol."},{"key":"75132_CR33","doi-asserted-by":"publisher","first-page":"e874","DOI":"10.1016\/j.ijid.2011.09.011","volume":"15","author":"Z Racil","year":"2011","unstructured":"Racil, Z. et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. Int. J. Infect. Dis. 15, e874-881 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"75132_CR34","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1128\/JCM.00467-14","volume":"52","author":"M Hoenigl","year":"2014","unstructured":"Hoenigl, M. et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 52, 2039\u20132045 (2014).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75132-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:24:36Z","timestamp":1670361876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75132-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75132-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"19 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17963"}}